🇺🇸 FDA
Patent

US 11865126

Method for treating anxiety disorders, headache disorders, and eating disorders with psilocybin

granted A61KA61K31/4045A61K31/661

Quick answer

US patent 11865126 (Method for treating anxiety disorders, headache disorders, and eating disorders with psilocybin) held by Compass Pathfinder Limited expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Compass Pathfinder Limited
Grant date
Tue Jan 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K31/4045, A61K31/661, A61K31/675, A61K9/0053